SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-068501
Filing Date
2020-06-01
Accepted
2020-06-01 17:32:04
Documents
1
Period of Report
2020-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2021119-2_4.html 4  
1 OWNERSHIP DOCUMENT tm2021119-2_4.xml 4 6378
  Complete submission text file 0001104659-20-068501.txt   8151
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 1325 AVENUE OF AMERICAS, 28TH FLR. NEW YORK NY 10019
Business Address
Lindborg Stacy (Reporting) CIK: 0001813667 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36641 | Film No.: 20934876